LVAD DT denied for missing prior authorization by Aetna?

Aetna's specific coverage criteria for lvad dt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Requires Prior Authorization for LVAD Destination Therapy — And How to Appeal a Denial

LVAD destination therapy is among the highest-cost cardiac interventions, and Aetna requires prior authorization before implantation. A denial at the prior-authorization stage does not mean coverage is permanently refused — it means Aetna's initial review found the submitted documentation insufficient to approve the procedure under its coverage criteria. These denials are frequently overturned on appeal when complete clinical documentation is presented.

## Why This Denial Is Appealable

Prior-authorization denials are inherently document-driven. Aetna's clinical reviewers work from the information submitted at the time of the request; if key records were missing, incomplete, or did not explicitly address Aetna's coverage criteria, a denial can be reversed by supplying that information on appeal. The appeal is your opportunity to build a complete, criteria-mapped record.

## Federal Appeal Framework

• Internal appeal: You (or your provider) must file a written appeal within the timeframe in the denial letter. For urgent cardiac situations, request expedited review — Aetna is required to respond within 72 hours.
• External review (ACA §2719): If the internal appeal is denied, an independent external review by an accredited IRO is available. The external review window opens after a final internal denial and is generally accessible within four months of that decision.
• Expedited external review: Available simultaneously with an expedited internal appeal when the condition is urgent or life-threatening — critical for patients awaiting LVAD implantation.
• ERISA §503: Employer-sponsored plans must provide a full-and-fair review of all submitted evidence, including new documentation not included in the original PA request.

## Documentation to Gather

• Cardiology evaluation records: full heart failure workup, most recent echocardiogram, catheterization data, and functional status assessments
• Prior treatment history: a chronological summary of all prior medical therapies — including medication names, dates initiated, doses tried, and reason for discontinuation or inadequate response — demonstrating that guideline-directed medical therapy has been optimized
• Multi-disciplinary team documentation: notes from a heart failure specialist, cardiac surgeon, and (where applicable) palliative care, reflecting the team's consensus that destination therapy is appropriate
• Clinical severity measures: objective data from the chart supporting advanced heart failure status
• Prescriber medical-necessity letter: a detailed letter from the implanting surgeon and/or heart failure cardiologist specifically addressing each criterion in Aetna's clinical policy bulletin for LVAD/destination therapy
• Aetna's current coverage policy: obtain and review the applicable clinical policy bulletin so your submission addresses every listed criterion

## Criteria-Mapping Structure

For each criterion listed in Aetna's published LVAD/destination therapy policy, write a direct, evidence-backed response citing the corresponding chart document, date, and finding. Structure the appeal letter so each policy requirement has a matching paragraph. This approach eliminates ambiguity and makes it difficult for Aetna to sustain the denial without specifically explaining why the submitted evidence is insufficient. Attach all referenced records as labeled exhibits.